AIRS on Nasdaq
Airsculpt Technologies, Inc.
Price unavailable
Last updated Oct 16, 2026.
Overview
Compare with SBC Medical Group Holdings Inc, LifeMD, Inc. or Concord Medical Services Holdings Ltd, or pick any stock.
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
-7.6%Operating margin3
-7.7%Net margin3
-15.8%Revenue growth, 20253
-13.3%Return on equity3
0.58×Debt to equity3
$692.0KFree cash flow3
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Selling, general and admin54¢$82.2M
- Other costs42¢$63.7M
- Income tax4¢$6.0M
Out of $151.8M in revenue.3 The company lost money this year.
Where each dollar of operating cash went, fiscal 2025
- Capital spending78¢$2.4M
- Kept or used elsewhere22¢$692.0K
Out of $3.1M of cash from operations.3
Financial statements
Every line of the income statement in the latest annual report, as filed.3
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Revenue | $151.8M | $180.3M | $195.9M |
| Cost of service (exclusive of depreciation and amortization) | $61.7M | $71.1M | $73.8M |
| Selling, general and administrative | $82.2M | $98.9M | $102.4M |
| Depreciation and amortization | $12.8M | $11.9M | $10.3M |
| Loss/(gain) on disposal of long-lived assets | $4.6M | $16.0K | -$212.0K |
| Total operating expenses | $163.4M | $181.9M | $186.2M |
| (Loss)/income from operations | -$11.6M | -$1.6M | $9.7M |
| Interest expense, net | $6.1M | $6.2M | $6.5M |
| Pre-tax net loss | -$17.6M | -$7.8M | $3.2M |
| Total | -$6.0M | $188.0K | $7.5M |
| Net loss | -$11.7M | -$8.0M | -$4.2M |
| Basic (in dollars per share) | -$0.19 | -$0.14 | -$0.08 |
| Diluted (in dollars per share) | -$0.19 | -$0.14 | -$0.08 |
| Basic (in shares) | 60.5M shares | 57.7M shares | 56.8M shares |
| Diluted (in shares) | 60.5M shares | 57.7M shares | 56.8M shares |
| Cost related to closing facility, net | $2.2M | $0 | $0 |
| Impairment of long-lived assets to be disposed of | $4.6M | $16.0K | -$212.0K |
| Operating lease, accelerated amortization expense | $3.3M | ||
| Gain on deconsolidation | $3.2M | ||
| Reclassification of cumulative translation adjustment | $255.0K | $0 | $0 |
Every line of the balance sheet in the latest annual report, as filed.3
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Cash and cash equivalents | $8.4M | $8.2M | |
| Taxes receivable | $1.5M | $3.1M | |
| Prepaid expenses and other current assets | $5.5M | $5.8M | |
| Total current assets | $15.5M | $17.1M | |
| Property and equipment, net | $27.8M | $37.5M | |
| Other long-term assets | $3.0M | $5.4M | |
| Right of use operating lease assets | $22.5M | $29.4M | |
| Intangible assets, net | $36.8M | $41.6M | |
| Goodwill | $81.7M | $81.7M | |
| Total assets | $187.3M | $212.8M | |
| Accounts payable | $5.4M | $6.3M | |
| Accrued payroll and benefits | $2.6M | $2.5M | |
| Current portion of long-term debt | $5.5M | $4.2M | |
| Deferred revenue and patient deposits | $1.9M | $1.2M | |
| Accrued and other current liabilities | $5.3M | $8.3M | |
| Current operating lease liabilities | $7.3M | $6.4M | |
| Total current liabilities | $27.9M | $28.9M | |
| Long-term debt, net | $50.6M | $65.5M | |
| Deferred tax liability, net | $878.0K | $6.6M | |
| Long-term operating lease liabilities | $20.2M | $27.8M | |
| Revolving credit funds payable | $0 | $5.0M | |
| Other long-term liabilities | $0 | $817.0K | |
| Total liabilities | $99.6M | $134.6M | |
| Common stock, $0.001 par value; shares authorized - 450,000,000; shares issued and outstanding - 64,455,872 and 58,369,138, respectively | $64.0K | $58.0K | |
| Additional paid-in capital | $128.3M | $107.7M | |
| Accumulated other comprehensive loss | -$96.0K | -$687.0K | |
| Accumulated deficit | -$40.6M | -$28.9M | |
| Total stockholders' equity | $87.7M | $78.2M | $82.7M |
| Total liabilities and stockholders' equity | $187.3M | $212.8M | |
| Common stock, par value (in dollars per share) | $0.00 | $0.00 | |
| Common stock, authorized (in shares) | 450.0M shares | 450.0M shares | |
| Common stock, issued (in shares) | 64.5M shares | 58.4M shares | |
| Common stock, outstanding (in shares) | 64.5M shares | 58.4M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow in the latest annual report, as filed.3
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Net loss | -$11.7M | -$8.0M | -$4.2M |
| Depreciation and amortization | $12.8M | $11.9M | $10.3M |
| Equity-based compensation | $2.3M | $3.8M | $18.2M |
| Non-cash interest expense; amortization of debt costs | $525.0K | $339.0K | $207.0K |
| Deferred income taxes | -$5.9M | -$252.0K | $1.3M |
| Loss on impairment of long-lived assets | $4.6M | $16.0K | -$212.0K |
| Cost related to closing location | $2.2M | $0 | $0 |
| Taxes receivable | $1.6M | -$1.1M | $890.0K |
| Prepaid expense and other current assets | -$4.4M | -$2.1M | $466.0K |
| Other assets | $6.7M | -$2.9M | -$4.7M |
| Accounts payable | $579.0K | $739.0K | -$206.0K |
| Deferred revenue and patient deposits | $735.0K | -$293.0K | -$896.0K |
| Accrued and other liabilities | -$6.8M | $9.2M | $2.8M |
| Net cash used in operating activities | $3.1M | $11.3M | $24.0M |
| Purchases of property and equipment, net | -$2.4M | -$14.0M | -$9.9M |
| Net cash used in investing activities | -$2.4M | -$14.0M | -$9.9M |
| Payments on term loan | -$13.8M | -$2.1M | -$12.1M |
| Payments for debt modification | -$393.0K | -$136.0K | $0 |
| Payments on revolving credit facility | -$5.0M | $5.0M | $0 |
| Proceeds from public offerings, net | $18.8M | $0 | $0 |
| Distribution to member | $0 | $0 | -$79.0K |
| Dividends paid to shareholders | $0 | -$252.0K | -$385.0K |
| Payment of taxes withheld through vested equity-based compensation | -$56.0K | -$903.0K | -$233.0K |
| Other financing activity | $0 | -$954.0K | -$569.0K |
| Net cash used in financing activities | -$478.0K | $630.0K | -$13.4M |
| Net decrease in cash and cash equivalents | $214.0K | -$2.0M | $646.0K |
| Cash paid for interest | $5.6M | $6.0M | $6.3M |
| Property and equipment included in accounts payable and accrued expenses | $1.6M | $1.6M | $283.0K |
Recent filings
- Aug 12, 20268-K
- Aug 12, 2026SCHEDULE 13G/A
- Aug 10, 20268-K
- Aug 10, 202610-Q
- Aug 10, 2026SCHEDULE 13G/A
- Jun 1, 2026SCHEDULE 13G
- May 20, 20264 OWNERSHIP DOCUMENT
- May 14, 20268-K
- May 14, 20264
- May 14, 20264
- May 14, 20264
- May 8, 20268-K
- May 8, 202610-Q
- Apr 21, 2026SCHEDULE 13G/A
- Apr 20, 20264 OWNERSHIP DOCUMENT
Every filing from the last three years, summarized. The full record is on SEC EDGAR.1
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9